Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Nov 2021 - Oct 2022
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Association of Clinical Research Organizations (ACRO)
EU Transparency Register
150920420956-26 First registered on 07 Mar 2016
Goals / Remit
ACRO and its members advocate on a global basis for safe, ethical, high-quality medical research so patients can benefit from the development of new treatments and therapies. Our members are dedicated to helping their clients bring efficiency, innovation and value to the clinical research process.
The Association of Clinical Research Organizations (ACRO) represents both (1) the world's leading, global clinical research organizations (CROs) and (2) global technology companies. Our member companies provide a wide range of specialized services across the entire spectrum of development for new drugs, biologics and medical devices – from discovery, pre-clinical, proof of concept and first-in-man studies through post-approval and pharmacovigilance research. ACRO advances clinical outsourcing to improve the quality, efficiency and safety of biomedical research.Main EU files targeted
As the voice of leading global CROs (clinical research organizations) and global technology companies, ACRO monitors and analyzes initiatives, policies, legislation, and regulation impacting clinical research and drug development. In addition to participating in numerous public consultations and numerous industry stakeholder workshops on multiple topics within the clinical research enterprise, ACRO and its members are deeply engaged in addressing the requirements of the EU Clinical Trial Regulation and the General Data Protection Regulation. ACRO also follows initiatives and policies on innovation in clinical research and trial design -- in addition to the increasing digitization of clinical trials (e.g., decentralized clinical trials; electronic consent; electronic signatures; and emerging topics such as the potential and promise of artificial intelligence and machine learning to assist in drug development).
Address
Head Office
601 New Jersey Ave NW Suite 350
Washington 20001
UNITED STATESEU Office
601 New Jersey Ave NW Suite 350
Washington 20001
UNITED STATESWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
The ACRO Senior Vice President of Global Regulatory Policy is 1/3 (one third) of an FTE.
The ACRO Regulatory Consultant is 1/8 (one eighth) of an FTE.Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Nov 2021 - Oct 2022
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
None declared
Meetings
Meetings
None declared